ArticleBMC infectious diseases2025
Epidemiological profile and transmission of mpox in the Kamituga health zone of South Kivu, Democratic Republic of Congo: a cross-sectional prospective study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Portable Detection of Monkeypox virus Clades using Bridging LAMP.Research square · 2026Article
- Trends of Pathogenicity and Potential Risk Evaluation of Central African Mpox Variant to Cause Global Public Health Emergency: A Cross-Sectional Analysis.Health science reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMonkeypox (mpox) remains a major global public health problem due to its rapid transmission, clinical severity and high case-fatality rate, especially for the clade I virus. Since August 2024, the disease was declared an public health emergency of international concern, with the resurgence of the disease cases and morbidity and mortality. Few studies exist in low-income countries. The Kamituga health zone (HZ) in South Kivu is the epicenter of the epidemic in the Democratic Republic of Congo (DRC). The aim of this study is to describe the transmission dynamics, epidemiological and clinical characteristics of mpox in this region.
methodsThis was a prospective cross-sectional study conducted over 9 months (October 2023 to June 2024) in the Kamituga HZ involving 160 confirmed patients. Data included seroprevalence, sociodemographic, epidemiological, clinical and behavioral characteristics. Variables were described by means, medians or proportions as appropriate; to compare proportions, Pearson’s chi-square, Z and Fisher’s exact tests were used. A margin of error of 5% was taken as threshold of statistical significance.
resultsSeroprevalence of mpox in Kamituga was 0.3%, well above the provincial average of 0,01% (p < 0,001). Over 80% of villages reported at least one case. The average age of patients was 23.5 years, with 58.7% women. Female sex workers accounted for 36.2% of cases. Around 26.3% had been in contact with an animal, mainly primate. mpox affected 52.2% of women with an sexual infected partner and 25.7% of men (p = 0.001). Overall, 70% of patients had more than one sexual partner in the last six months with more men (81.8%) than women (61.7%) (p = 0.003). Clinically, 86.3% presented with fever, and 91.9% with extensive pustular eruptions, predominantly genital (90%). Lymphadenopathy affected 98.7% of cases. Only 5.6% of patients had recovered fully.
conclusionmpox in Kamituga is alarmingly prevalent, affecting young adults and female sex workers with severe symptoms such as rashes and lymphandenopathy. Risky sexual behavior and late recourse to healthcare contribute to the spread of the disease. Urgent measures such as raising awareness, vaccine research and strengthening health infrastructures are essential. Collaboration between authorities, researchers and communities is important.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.